NCT00234403View on ClinicalTrials.gov

A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

October 31, 2007

Conditions

Breast Cancer

Interventions

DRUG

gefitinib and fulvestrant

Trial Locations (7)

Unknown

Investigative Site, Alicante

Investigative Site, Girona

Investigative Site, Jaén

Investigative Site, Madrid

Investigative Site, Seville

Investigative Site, Valencia

Investigative Site, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY